Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients Biotech Investing
Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE Biotech Investing
Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor Biotech Investing
RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand Cannabis Investing News
Roche and Foundation Medicine Reach Definitive Merger Agreement to Accelerate Broad Availability of Comprehensive Genomic Profiling in Oncology Biotech Investing
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology Biotech Investing
Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China Pharmaceutical Investing
Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation Biotech Investing
Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration Biotech Investing
